vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Southland Holdings, Inc.（SLND）财务数据对比。点击上方公司名可切换其他公司
Southland Holdings, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$104.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -61.1%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $9.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -39.9%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Southland Holdings, Inc.是北美知名基础设施建设企业，主营公路、桥梁、机场等交通工程、水处理系统搭建及商业场地开发业务，服务公共部门及私营领域客户，业务覆盖北美核心市场。
PBYI vs SLND — 直观对比
营收规模更大
SLND
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出88.8%
-61.1%
自由现金流更多
PBYI
多$5.1M
$9.3M
两年增速更快
PBYI
近两年复合增速
-39.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $104.0M |
| 净利润 | — | $-216.4M |
| 毛利率 | 69.3% | -186.0% |
| 营业利润率 | 22.7% | -202.4% |
| 净利率 | — | -208.2% |
| 营收同比 | 27.7% | -61.1% |
| 净利润同比 | — | -5108.5% |
| 每股收益（稀释后） | $0.26 | $-4.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISLND
| Q4 25 | $75.5M | $104.0M | ||
| Q3 25 | $54.5M | $213.3M | ||
| Q2 25 | $52.4M | $215.4M | ||
| Q1 25 | $46.0M | $239.5M | ||
| Q4 24 | $59.1M | $267.3M | ||
| Q3 24 | $80.5M | $173.3M | ||
| Q2 24 | $47.1M | $251.5M | ||
| Q1 24 | $43.8M | $288.1M |
净利润PBYISLND
| Q4 25 | — | $-216.4M | ||
| Q3 25 | $8.8M | $-75.3M | ||
| Q2 25 | $5.9M | $-10.3M | ||
| Q1 25 | $3.0M | $-4.6M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | $20.3M | $-54.7M | ||
| Q2 24 | $-4.5M | $-46.1M | ||
| Q1 24 | $-4.8M | $-406.0K |
毛利率PBYISLND
| Q4 25 | 69.3% | -186.0% | ||
| Q3 25 | 77.7% | 1.5% | ||
| Q2 25 | 76.5% | 6.2% | ||
| Q1 25 | 77.1% | 9.0% | ||
| Q4 24 | 76.4% | 2.9% | ||
| Q3 24 | 63.9% | -29.5% | ||
| Q2 24 | 77.4% | -15.9% | ||
| Q1 24 | 75.5% | 7.1% |
营业利润率PBYISLND
| Q4 25 | 22.7% | -202.4% | ||
| Q3 25 | 17.6% | -5.3% | ||
| Q2 25 | 12.7% | -0.1% | ||
| Q1 25 | 8.7% | 2.1% | ||
| Q4 24 | 22.6% | -3.0% | ||
| Q3 24 | 27.4% | -39.6% | ||
| Q2 24 | -4.6% | -22.1% | ||
| Q1 24 | -5.3% | 2.1% |
净利率PBYISLND
| Q4 25 | — | -208.2% | ||
| Q3 25 | 16.2% | -35.3% | ||
| Q2 25 | 11.2% | -4.8% | ||
| Q1 25 | 6.5% | -1.9% | ||
| Q4 24 | — | -1.6% | ||
| Q3 24 | 25.2% | -31.6% | ||
| Q2 24 | -9.6% | -18.3% | ||
| Q1 24 | -11.0% | -0.1% |
每股收益（稀释后）PBYISLND
| Q4 25 | $0.26 | $-4.01 | ||
| Q3 25 | $0.17 | $-1.39 | ||
| Q2 25 | $0.12 | $-0.19 | ||
| Q1 25 | $0.06 | $-0.08 | ||
| Q4 24 | $0.40 | $-0.08 | ||
| Q3 24 | $0.41 | $-1.14 | ||
| Q2 24 | $-0.09 | $-0.96 | ||
| Q1 24 | $-0.10 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $52.7M |
| 总债务越低越好 | $22.7M | $257.7M |
| 股东权益账面价值 | $130.3M | $-140.9M |
| 总资产 | $216.3M | $989.3M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISLND
| Q4 25 | $97.5M | $52.7M | ||
| Q3 25 | $94.4M | $40.5M | ||
| Q2 25 | $96.0M | $46.5M | ||
| Q1 25 | $93.2M | $65.1M | ||
| Q4 24 | $101.0M | $72.2M | ||
| Q3 24 | $96.7M | $91.4M | ||
| Q2 24 | $96.8M | $52.4M | ||
| Q1 24 | $107.2M | $31.2M |
总债务PBYISLND
| Q4 25 | $22.7M | $257.7M | ||
| Q3 25 | $34.0M | $267.8M | ||
| Q2 25 | $45.3M | $278.6M | ||
| Q1 25 | $56.7M | $288.1M | ||
| Q4 24 | $68.0M | $300.1M | ||
| Q3 24 | $79.3M | $318.3M | ||
| Q2 24 | $90.7M | $307.8M | ||
| Q1 24 | $102.0M | $302.0M |
股东权益PBYISLND
| Q4 25 | $130.3M | $-140.9M | ||
| Q3 25 | $115.3M | $75.0M | ||
| Q2 25 | $104.7M | $151.1M | ||
| Q1 25 | $97.1M | $159.1M | ||
| Q4 24 | $92.1M | $163.7M | ||
| Q3 24 | $71.1M | $149.1M | ||
| Q2 24 | $48.5M | $203.3M | ||
| Q1 24 | $51.0M | $249.3M |
总资产PBYISLND
| Q4 25 | $216.3M | $989.3M | ||
| Q3 25 | $202.9M | $1.1B | ||
| Q2 25 | $194.9M | $1.2B | ||
| Q1 25 | $196.2M | $1.2B | ||
| Q4 24 | $213.3M | $1.2B | ||
| Q3 24 | $220.7M | $1.2B | ||
| Q2 24 | $205.0M | $1.3B | ||
| Q1 24 | $214.1M | $1.2B |
负债/权益比PBYISLND
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | 3.57× | ||
| Q2 25 | 0.43× | 1.84× | ||
| Q1 25 | 0.58× | 1.81× | ||
| Q4 24 | 0.74× | 1.83× | ||
| Q3 24 | 1.12× | 2.14× | ||
| Q2 24 | 1.87× | 1.51× | ||
| Q1 24 | 2.00× | 1.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $9.7M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $9.3M |
| 自由现金流率自由现金流/营收 | 19.1% | 8.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $12.7M |
8季度趋势，按日历期对齐
经营现金流PBYISLND
| Q4 25 | $14.4M | $9.7M | ||
| Q3 25 | $9.7M | $5.9M | ||
| Q2 25 | $14.1M | $-5.4M | ||
| Q1 25 | $3.6M | $6.4M | ||
| Q4 24 | $15.6M | $-10.3M | ||
| Q3 24 | $11.0M | $-5.3M | ||
| Q2 24 | $1.0M | $27.4M | ||
| Q1 24 | $11.2M | $-9.9M |
自由现金流PBYISLND
| Q4 25 | $14.4M | $9.3M | ||
| Q3 25 | $9.7M | $5.3M | ||
| Q2 25 | $14.1M | $-6.5M | ||
| Q1 25 | $3.6M | $4.6M | ||
| Q4 24 | $15.6M | $-11.5M | ||
| Q3 24 | $11.0M | $-7.3M | ||
| Q2 24 | $1.0M | $26.3M | ||
| Q1 24 | — | $-13.0M |
自由现金流率PBYISLND
| Q4 25 | 19.1% | 8.9% | ||
| Q3 25 | 17.7% | 2.5% | ||
| Q2 25 | 26.8% | -3.0% | ||
| Q1 25 | 7.7% | 1.9% | ||
| Q4 24 | 26.4% | -4.3% | ||
| Q3 24 | 13.7% | -4.2% | ||
| Q2 24 | 2.1% | 10.5% | ||
| Q1 24 | — | -4.5% |
资本支出强度PBYISLND
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.0% | 1.1% |
现金转化率PBYISLND
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SLND
| Civil | $58.4M | 56% |
| Transportation | $45.6M | 44% |
